Cipralex Approved in Europe for the Treatment of Obsessive Compulsive Disorder

H. Lundbeck A/S is pleased to announce the approval of Cipralex® in Europe for the treatment of obsessive-compulsive disorder . The approval is based on two pivotal studies demonstrating that Cipralex® is effective and well-tolerated in the treatment of OCD with the added benefit of encouraging rates of remission and relapse prevention in OCD patients.1,2
From: biz.yahoo.com